| pubmed-article:155219 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C0007138 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C0037296 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C0012460 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C0020987 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:155219 | lifeskim:mentions | umls-concept:C1518062 | lld:lifeskim |
| pubmed-article:155219 | pubmed:issue | 49 | lld:pubmed |
| pubmed-article:155219 | pubmed:dateCreated | 1979-6-11 | lld:pubmed |
| pubmed-article:155219 | pubmed:abstractText | Patients with transitional cell carcinoma of the bladder have a highly significant stepwise decrease in responsiveness to challenge with DNCB with advancing stage of disease. Seventy-five percent of those patients with superficial tumors are skin-test positive versus only 35% for those having tumors that are locally advanced and/or metastatic. MLC response and ability to stimulate in this culture as well as PHA and Con A response of blood leukocytes have been studied in relation to stage of disease and therapy. Recent irradiation appears to inhibit significantly MLC responsiveness, and PHA and Con A blastogenesis. Although responsiveness for this group of patients is decreased from normal, a further decrease occurs in responsiveness to Con A with advancing stage of disease. Blood leukocytes from some patients with urinary bladder carcinoma appear to have a decreased ability to function as stimulator cells in one-way MLC. This ability to stimulate returns to normal levels with tumor removal. | lld:pubmed |
| pubmed-article:155219 | pubmed:language | eng | lld:pubmed |
| pubmed-article:155219 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:155219 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:155219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:155219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:155219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:155219 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:155219 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:155219 | pubmed:issn | 0083-1921 | lld:pubmed |
| pubmed-article:155219 | pubmed:author | pubmed-author:WhitmoreW... | lld:pubmed |
| pubmed-article:155219 | pubmed:author | pubmed-author:BeanM AMA | lld:pubmed |
| pubmed-article:155219 | pubmed:author | pubmed-author:HerbH GHG | lld:pubmed |
| pubmed-article:155219 | pubmed:author | pubmed-author:PinskyC MCM | lld:pubmed |
| pubmed-article:155219 | pubmed:author | pubmed-author:SchellhammerP... | lld:pubmed |
| pubmed-article:155219 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:155219 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:155219 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:155219 | pubmed:pagination | 111-4 | lld:pubmed |
| pubmed-article:155219 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-H... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-U... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-L... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-M... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-S... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-C... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-L... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-P... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-L... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-D... | lld:pubmed |
| pubmed-article:155219 | pubmed:meshHeading | pubmed-meshheading:155219-C... | lld:pubmed |
| pubmed-article:155219 | pubmed:year | 1978 | lld:pubmed |
| pubmed-article:155219 | pubmed:articleTitle | Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function. | lld:pubmed |
| pubmed-article:155219 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:155219 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:155219 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:155219 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
